A Retrospective, Multicenter Study Assessing the Effectiveness , Safety and Pharmacological Interactions of Ombitasvir/Paritaprevir/Ritonavir(OBV/PTV/r) ± Dasabuvir (DSV) ± Ribavirin (RBV) in Patients with Stage 4 or 5 Chronic Kidney Disease (CKD) and Hepatitis C Virus (HCV) Genotype 1 or 4 Infection in Real Clinical Practice

Trial Profile

A Retrospective, Multicenter Study Assessing the Effectiveness , Safety and Pharmacological Interactions of Ombitasvir/Paritaprevir/Ritonavir(OBV/PTV/r) ± Dasabuvir (DSV) ± Ribavirin (RBV) in Patients with Stage 4 or 5 Chronic Kidney Disease (CKD) and Hepatitis C Virus (HCV) Genotype 1 or 4 Infection in Real Clinical Practice

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Feb 2018

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top